Welcome to This Week in Ophthalmology. This week we're covering 9 notable papers spanning advances in retina, new evidence in cornea and anterior segment care, and insights into myopia and ophthalmic research methods. Let's dive in.

This week's papers:

1. Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR). — BMJ (Clinical research ed.) 2026
2. Antifungal Therapy for Fusarium Keratitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. — Cornea 2026
3. OCT-Based Quantitative Comparison of Full-Thickness Healing of Corneal Incisions in Cataract Surgery Between Diabetic and Nondiabetic Patients. — Cornea 2026
4. Real-World Insights on Switching Aflibercept Dosage for Enhanced Outcomes in Retinal Vein Occlusion (RISE-RVO): visual, anatomical and durability outcomes. — The British journal of ophthalmology 2026
5. Glaucoma in UK Biobank: A Comparison of Diagnostic- Versus Treatment-based Definitions. — Ophthalmology 2026
6. SEARCHING FOR NEW GENES THAT CAUSE USHER SYNDROME. — American journal of ophthalmology 2026
7. PROSTACYCLIN ANALOGS AND DIABETIC RETINOPATHY OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION : A Cohort Analysis. — Retina (Philadelphia, Pa.) 2026
8. Can switching between different types of myopia control spectacles enhance effectiveness? Findings from a real-world study. — The British journal of ophthalmology 2026
9. Descemet Stripping Only in Fuchs Endothelial Corneal Dystrophy: Results of a Randomized Clinical Trial of Topical Ripasudil and Directions for Future Innovation. — American journal of ophthalmology 2026

Listen at AudioScholar